News about Market

Apollo Hospitals may garner 14% market share in e-pharmacy business in next five years: Motilal Oswal report

Healthcare major Apollo Hospitals Enterprises Ltd (AHEL) is expected to see its e-pharmacy business to gain around 14 per cent market share over the next five years, driven by the omni-channel model it is currently working on, according to a latest report from Motilal Oswal Financial Services Ltd (MOFSL)

Market | 24/12/2021 | By Darshana |  301

Encube Ethicals to acquire Soframycin for India and Sri Lanka markets from Sanofi

Encube Ethicals has agreed to enter into definitive agreements with Sanofi group and its affiliates, including Sanofi India for acquiring some of its brands ? Soframycin, along with other legacy-associated brands Sofradex, Sofracort, Soframycin-Tulle for India and Sri Lanka markets, a statement from Encube notified

Market | 27/11/2021 | By Darshana |  291

Jubilant Pharmova Q2 net profit stood at Rs.143 crore

The company's radiopharma business witnessed improvement in sales YoY, however pace of recovery during the quarter was affected by increase in Covid-19 cases in the US, while CMO business revenue grew YoY based on continued strong demand from customers as well as due to Covid related deals

Market | 24/10/2021 | By Darshana |  228

Doceree introduces opti-channel marketing for pharma sector in India

Doceree, the first global network of physician-only platforms for programmatic messaging, launched in India opti-channel marketing for the pharmaceutical sector, in its attempt to accelerate adoption of digital mediums in an industry which is relatively slow in embracing innovative digital technologies

Market | 28/09/2021 | By Darshana |  256

Indian API, CRAMS sectors to outperform other countries during 2021-26: research report

The Indian active pharmaceutical ingredients (API) sector is expected to outperform other countries with an estimated Compound Annual Growth Rate (CAGR) of 9.6 per cent over the calendar year 2021-26, while complex APIs would see a faster growth owing to the focus on complex formulations and others

Market | 13/09/2021 | By Darshana |  294

Deal value in pharma industry decreases by 67.2 per cent in August: Globalata

The latest GlobalData report has revealed that the pharmaceutical industry reported 56 deals worth $11.7 billion last month as compared to the last 12-month average (August 2020 to July 2021) of 104 deals worth $28.9 billion

Market | 08/09/2021 | By Darshana |  212

RIL arm acquires stake in Strand Life Sciences

Reliance Strategic Business Ventures Limited, a wholly owned subsidiary of Reliance Industries Limited has acquired stake in Strand Life Sciences for a cash consideration of Rs. 393 crore

Market | 04/09/2021 | By Darshana |  179

Pfizer to acquire Trillium Therapeutics

Pfizer and Trillium Therapeutics yesterday announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer. Under the terms of the agreement

Market | 24/08/2021 | By Darshana |  295

NPPA caps trade margin of 42 anti-cancer medicines, MRP of 562 brands gets reduced up to 90%

The National Pharmaceutical Pricing Authority (NPPA) has put a cap on trade margin of 42 select non-scheduled anti-cancer medicines under the "Trade Margin Rationalization (TMR)"

Market | 11/08/2021 | By Darshana |  204

DCGI classifies 51 medical devices related to respiratory health under rules

The Drugs Controller General (India) has classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules, 2017, the rule formed to regulate them with respect to the import, manufacture, sale and distribution, and clinical investigation

Market | 10/08/2021 | By Darshana |  156